Braasch Biotech LLC, an emerging biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today announced a Notice of Allowance was received from the Japan Patent Office on July 15, 2025, for Braasch's patent entitled...
In response to growing consumer demand for transparency and healthier dairy options, a new independent organization has launched a pioneering initiative: the NonBCM7™ Certified program.
